The DOI matches its Crossref record; 337 of the 337 references it cites were found in a registry or an index.
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections
Open accessAbstract
Infections with Pseudomonas aeruginosa have become a concerning threat in hospital-acquired infections and for cystic fibrosis patients. The major problem leading to high mortality lies in the appearance of drug-resistant strains. Therefore, a vast number of approaches to develop novel anti-infectives is currently pursued. These diverse strategies span from killing (new antibiotics) to disarming (antivirulence) the pathogen. Particular emphasis lies on the development of compounds that inhibit biofilms formed in chronic infections to restore susceptibility toward antibiotics. Numerous promising results are summarized in this perspective. Antibiotics with a novel mode of action will be needed to avoid cross resistance against currently used therapeutic agents. Importantly, antivirulence drugs are expected to yield a significantly reduced rate of resistance development. Most developments are still far from the application. It can however be expected that combination therapies, also containing antivirulence agents, will pave the way toward novel treatment options against P. aeruginosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–337 of 337
Inhibition of Pseudomonas aeruginosa Biofilm Formation with Bromoageliferin Analogues
Huigens, R. W., Richards, J. J., Sloan, G. P., Ballard, T. E., Zeng, W., Deora, R., & Melander, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja069017t · Cited by 145
Dulcey, C. E., Dekimpe, V., Fauvelle, D.-A., Milot, S. M., Groleau, M., Doucet, N., Rahme, L. G., Lepine, F. L., & Déziel, É. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.021 · Cited by 144
Antimicrobial Peptides with Stability toward Tryptic Degradation
Svenson, J., Stensen, W., Brandsdal, B. O., Haug, B. E., Monrad, J., & Svendsen, J. S. M. (2008) · Biochemistry · doi:10.1021/bi7019904 · Cited by 143
Repurposing of gallium‐based drugs for antibacterial therapy
Bonchi, C., Imperi, F., Minandri, F., Visca, P., & Frangipani, E. (2014) · BioFactors · doi:10.1002/biof.1159 · Cited by 142
2‐Aminobenzimidazole Derivatives Strongly Inhibit and Disperse Pseudomonas aeruginosa Biofilms
Frei, R., Breitbach, A. S., & Blackwell, H. E. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201109258 · Cited by 142
Perret, S., Sabin, C., Dumon, C., Pokorná, M., Gautier, C., Galanina, O. E., Ilia, S., Bovin, N. V., Nicaise, M., Desmadril, M., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050079 · Cited by 140
Müh, U., Hare, B. J., Duerkop, B. A., Schuster, M., Hanzelka, B. L., Heim, R., Olson, E. R., & Greenberg, E. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608348103 · Cited by 138
Høiby, N. (2002) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(02)00104-2 · Cited by 138
Cathcart, G. R., Quinn, D. J., Greer, B., Harriott, P., Lynas, J. F., Gilmore, B., & Walker, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00776-10 · Cited by 137
Page, M. G. P. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12024 · Cited by 136
Kida, Y., Higashimoto, Y., Inoue, H., Shimizu, T., & Kuwano, K. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01142.x · Cited by 135
Yoshida, K., Nakayama, K., Ohtsuka, M., Kuru, N., Yokomizo, Y., Sakamoto, A., Takemura, M., Hoshino, K., Kanda, H., Nitanai, H., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.07.039 · Cited by 134
Structural Basis of Carbohydrate Recognition by the Lectin LecB from Pseudomonas aeruginosa
Loris, R., Tielker, D., Jaeger, K., & Wyns, L. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00754-x · Cited by 133
The Key Role of Pseudomonas aeruginosa PA-I Lectin on Experimental Gut-Derived Sepsis
Laughlin, R. S., Musch, M. W., Holbrook, C., Rocha, F., Chang, E. B., & Alverdy, J. C. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00019 · Cited by 132
The twin-arginine transport system: moving folded proteins across membranes
Sargent, F. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350835 · Cited by 132
The evolution explosion: how humans cause rapid evolutionary change
(2001) · Choice Reviews Online · doi:10.5860/choice.39-1550 · Cited by 128
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
Askoura, M., Mattawa, W., Abujamel, T. S., & Taher, I. (2011) · Libyan Journal of Medicine · doi:10.3402/ljm.v6i0.5870 · Cited by 127
Velkov, T., Roberts, K. D., Nation, R. L., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500080r · Cited by 127
Lieberman, O. J., Orr, M. W., Wang, Y., & Lee, V. T. (2013) · ACS Chemical Biology · doi:10.1021/cb400485k · Cited by 127
Storz, M. P., Maurer, C. K., Zimmer, C., Wagner, N., Brengel, C., de Jong, J. C., Lucas, S., Müsken, M., Häußler, S., Steinbach, A., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3072397 · Cited by 126
Self-citationLu, C., Kirsch, B., Zimmer, C., de Jong, J. C., Henn, C., Maurer, C. K., Müsken, M., Häußler, S., Steinbach, A., & Hartmann, R. W. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.015 · Cited by 126
Self-citationDavril, M., Groux‐Degroote, S., Humbert, P., et al. (1999) · Glycobiology · doi:10.1093/glycob/9.3.311 · Cited by 126
Drees, S. L., & Fetzner, S. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.04.012 · Cited by 125
Role of PvdQ in Pseudomonas aeruginosa virulence under iron-limiting conditions
Nadal‐Jimenez, P., Koch, G., Papaioannou, E., Wahjudi, M., Krzeslak, J., Coenye, T., Cool, R. H., & Quax, W. J. (2009) · Microbiology · doi:10.1099/mic.0.030973-0 · Cited by 125
Stach, M., Siriwardena, T. N., Köhler, T., van Delden, C., Darbre, T., & Reymond, J. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409270 · Cited by 123
Inhaled Lactonase Reduces Pseudomonas aeruginosa Quorum Sensing and Mortality in Rat Pneumonia
Hraiech, S., Hiblot, J., Lafleur, J., Lépidi, H., Papazian, L., Rolain, J., Raoult, D., Elias, M. H., Silby, M. W., Bzdrenga, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107125 · Cited by 120
Aromatic thioglycoside inhibitors against the virulence factor LecA from Pseudomonas aeruginosa
Rodrigue, J., Ganne, G., Blanchard, B., Saucier, C., Giguère, D., Shiao, T. C., Varrot, A., Imberty, A., & Roy, R. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41422a · Cited by 119
Cecioni, S., Praly, J., Matthews, S. E., Wimmerová, M., Imberty, A., & Vidal, S. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201200010 · Cited by 119
Warrener, P., Varkey, R., Bonnell, J. C., DiGiandomenico, A., Camara, M., Cook, K. E., Li, P., Zha, J., Chowdury, P., Sellman, B. R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02643-14 · Cited by 119
Tomaras, A. P., McPherson, C. J., Kuhn, M., Carifa, A., Mullins, L. M., George, D. M., Desbonnet, C. R., Eidem, T. M., Montgomery, J. I., Brown, M. F., et al. (2014) · mBio · doi:10.1128/mbio.01551-14 · Cited by 117
Rogers, S. A., & Melander, C. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800862 · Cited by 116
Sambanthamoorthy, K., Luo, C., Pattabiraman, N., Feng, X., Koestler, B. J., Waters, C. M., & Palys, T. J. (2013) · Biofouling · doi:10.1080/08927014.2013.832224 · Cited by 116
Dioxygenase-Mediated Quenching of Quinolone-Dependent Quorum Sensing in Pseudomonas aeruginosa
Pustelny, C., Albers, A., Büldt‐Karentzopoulos, K., Parschat, K., Chhabra, S. R., Cámara, M., Williams, P. M., & Fetzner, S. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.11.013 · Cited by 116
Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli
Bohnert, J. A., Szymaniak-Vits, M., Schuster, S., & Kern, W. V. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr258 · Cited by 114
Giltner, C. L., van Schaik, E. J., Audette, G. F., Kao, D., Hodges, R. S., Hassett, D. J., & Irvin, R. T. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05085.x · Cited by 114
Piddock, L. J. V., Garvey, M. I., Rahman, M. M., & Gibbons, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq079 · Cited by 111
Barb, A. W., Jiang, L., Raetz, C. R. H., & Zhou, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709412104 · Cited by 111
Létoffé, S., Nato, F., Goldberg, M. E., & Wandersman, C. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01499.x · Cited by 109
Milla, C. E., Chmiel, J. F., Accurso, F. J., VanDevanter, D. R., Konstan, M. W., Yarranton, G. T., Geller, D. E., & for the KB001 Study Group (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22890 · Cited by 109
Papaioannou, E., Wahjudi, M., Nadal‐Jimenez, P., Koch, G., Setroikromo, R., & Quax, W. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00380-09 · Cited by 109
Gaspar, M. C., Couet, W. R., Olivier, J., Pais, A. A. C. C., & Sousa, J. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1876-y · Cited by 108
Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections
van der Does, A. M., Bergman, P., Agerberth, B., & Lindbom, L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412178 · Cited by 108
Species-Specific and Inhibitor-Dependent Conformations of LpxC: Implications for Antibiotic Design
Lee, C.-J., Liang, X., Chen, X., Zeng, D., Joo, S. H., Chung, H. S., Barb, A. W., Swanson, S. M., Nicholas, R. A., Li, Y., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.11.011 · Cited by 105
Lu, C., Maurer, C. K., Kirsch, B., Steinbach, A., & Hartmann, R. W. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201307547 · Cited by 105
Self-citationGarber, N. C., Guempel, U. M., Belz, A., et al. (1992) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(92)90048-y · Cited by 104
García‐Contreras, R., Martínez‐Vázquez, M., Velázquez‐Guadarrama, N., Pañeda, A. G. V., Hashimoto, T., Maeda, T., Quezada, H., & Wood, T. K. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12039 · Cited by 104
Novoa, A., Eierhoff, T., Topin, J., Varrot, A., Barluenga, S., Imberty, A., Römer, W., & Winssinger, N. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402831 · Cited by 102
Hultqvist, L. D., van Gennip, M., Rybtke, M., Wu, H. W., Chiang, W., Alhede, M., Høiby, N., Nielsen, T. E., Givskov, M., & Tolker‐Nielsen, T. (2013) · Infection and Immunity · doi:10.1128/iai.00332-13 · Cited by 102
Sambanthamoorthy, K., Gokhale, A. A., Lao, W., Parashar, V., Neiditch, M. B., Semmelhack, M. F., Lee, I., & Waters, C. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00583-11 · Cited by 101
Scharfman, A., Arora, S. K., Delmotte, P. F., Brussel, E. V., Mazurier, J., Ramphal, R., & Roussel, P. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5243-5248.2001 · Cited by 101
Kadam, R. U., Garg, D., Schwartz, J., Visini, R., Sattler, M., Stocker, A., Darbre, T., & Reymond, J. (2013) · ACS Chemical Biology · doi:10.1021/cb400303w · Cited by 101
Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections
Brown, M. F., Reilly, U. D., Abramite, J. A., Arcari, J. T., Oliver, R., Barham, R. A., Che, Y., Chen, J. M., Collantes, E. M., Chung, S. W., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2014748 · Cited by 100
Drake, E. J., & Gulick, A. M. (2011) · ACS Chemical Biology · doi:10.1021/cb2002973 · Cited by 98
Sajjan, U. S., Tran, L. T., Solé, N. A., Rovaldi, C., Akiyama, A., Friden, P. M., Forstner, J., & Rothstein, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3437-3444.2001 · Cited by 98
Pseudomonas aeruginosa tssC1 Links Type VI Secretion and Biofilm-Specific Antibiotic Resistance
Zhang, L., Hinz, A., Nadeau, J., & Mah, T. (2011) · Journal of Bacteriology · doi:10.1128/jb.00268-11 · Cited by 98
Geske, G. D., Mattmann, M. E., & Blackwell, H. E. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.089 · Cited by 97
Brutinel, E. D., Vakulskas, C. A., Brady, K. M., & Yahr, T. L. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06179.x · Cited by 96
Hauck, D., Joachim, I., Frommeyer, B., Varrot, A., Philipp, B., Möller, H. M., Imberty, A., Exner, T. E., & Titz, A. (2013) · ACS Chemical Biology · doi:10.1021/cb400371r · Cited by 96
Self-citationByrd, M. S., Pang, B., Mishra, M., Swords, W. E., & Wozniak, D. J. (2010) · mBio · doi:10.1128/mbio.00140-10 · Cited by 93
Bröms, J. E., Meyer, L., Lavander, M., Larsson, P., & Sjöstedt, A. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034639 · Cited by 93
Molecular Validation of LpxC as an Antibacterial Drug Target in Pseudomonas aeruginosa
Mdluli, K. E., Witte, P. R., Kline, T. B., Barb, A. W., Erwin, A. L., Mansfield, B. E., McClerren, A. L., Pirrung, M. C., Tumey, L. N., Warrener, P., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00140-06 · Cited by 93
Mily, A., Rekha, R. S., Kamal, S. M. M., Akhtar, E., Sarker, P., Rahim, Z., Gudmundsson, G. H., Agerberth, B., & Raqib, R. (2013) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-13-23 · Cited by 92
Berthelot, P., Attrée, I., Plésiat, P., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377000 · Cited by 91
Towards understanding Pseudomonas aeruginosa burn wound infections by profiling gene expression
Bielecki, P., Glik, J., Kawecki, M., & dos Santos, V. A. P. M. (2007) · Biotechnology Letters · doi:10.1007/s10529-007-9620-2 · Cited by 90
Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase
Ehmann, D. E., & Lahiri, S. D. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.007 · Cited by 86
New insight into the molecular mechanisms of two-partner secretion
Mazar, J., & Cotter, P. A. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.10.005 · Cited by 86
Klein, T., Henn, C., de Jong, J. C., Zimmer, C., Kirsch, B., Maurer, C. K., Pistorius, D., Müller, R., Steinbach, A., & Hartmann, R. W. (2012) · ACS Chemical Biology · doi:10.1021/cb300208g · Cited by 86
Self-citationNakayama, K., Ishida, Y., Ohtsuka, M., Kawato, H. C., Yoshida, K., Yokomizo, Y., Hosono, S., Ohta, T., Hoshino, K., Ishida, H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.024 · Cited by 86
A comprehensive assessment of N-terminal signal peptides prediction methods
Choo, K. H., Tan, T. W., & Ranganathan, S. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-s15-s2 · Cited by 84
Garrity-Ryan, L. K., Kim, O. K., Balada-Llasat, J.-M., Bartlett, V. J., Verma, A. K., Fisher, M. L., Castillo, C., Songsungthong, W., Tanaka, S. K., Levy, S. B., et al. (2010) · Infection and Immunity · doi:10.1128/iai.01305-09 · Cited by 83
Lehoux, D. E., Sanschagrin, F., & Lévesque, R. C. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09276.x · Cited by 82
Hodgkinson, J. T., Galloway, W. R. J. D., Wright, M. H., Mati, I. K., Nicholson, R. L., Welch, M., & Spring, D. R. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25198a · Cited by 82
Watkins, W. J., Landaverry, Y. R., Léger, R., Litman, R., Renau, T. E., Williams, N., Yen, R., Zhang, J. Z., Chamberland, S., Madsen, D., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.030 · Cited by 78
Anderson, M. S., Robertson, A. D., Macher, I., & Raetz, C. R. H. (1988) · Biochemistry · doi:10.1021/bi00406a017 · Cited by 78
Kaufmann, G. F., Park, J., Mee, J. M., Ulevitch, R. J., & Janda, K. D. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.010 · Cited by 74
Structural Basis for Type VI Secretion Effector Recognition by a Cognate Immunity Protein
Li, M., Trong, I. L., Carl, M. A., Larson, E. T., Chou, S., Leon, J. A. D., Dove, S. L., Stenkamp, R. E., & Mougous, J. D. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002613 · Cited by 74
Zetterström, C. E., Hasselgren, J., Salin, O., Davis, R. A., Quinn, R. J., Sundin, C., & Elofsson, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081969 · Cited by 73
Structural Insight into Multivalent Galactoside Binding to Pseudomonas aeruginosa Lectin LecA
Visini, R., Jin, X., Bergmann, M., Michaud, G., Pertici, F., Fu, O., Pukin, A. V., Branson, T. R., Thies‐Weesie, D. M. E., Kemmink, J., et al. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00302 · Cited by 71
Zender, M., Klein, T., Henn, C., Kirsch, B., Maurer, C. K., Kail, D., Ritter, C., Dolezal, O., Steinbach, A., & Hartmann, R. W. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400830r · Cited by 71
Self-citationManagement of refractory Pseudomonas aeruginosa infection in cystic fibrosis
Sordé, R., Pahissa, A., & Rello, J. (2011) · Infection and Drug Resistance · doi:10.2147/idr.s16263 · Cited by 70
Zhang, W., Sun, J., Ding, W., Lin, J., Tian, R., Lu, L., Liu, X., Shen, X., & Qian, P. (2015) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2015.00040 · Cited by 67
Kretz, J., Kerwat, D., Schubert, V., Grätz, S., Pesic, A., Semsary, S., Cociancich, S., Royer, M., & Süßmuth, R. D. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409584 · Cited by 67
Fullagar, J. L., Garner, A. L., Struss, A. K., Day, J. A., Martin, D. P., Yu, J., Cai, X., Janda, K. D., & Cohen, S. M. (2013) · Chemical Communications · doi:10.1039/c3cc41191e · Cited by 67
Guzzo, J., Murgier, M., Filloux, A., et al. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.2.942-948.1990 · Cited by 66
Defensin-based anti-infective strategies
Wilmes, M., & Sahl, H. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.08.007 · Cited by 66
Development of Potent Inhibitors of Pyocyanin Production inPseudomonas aeruginosa
Miller, L. C., O’Loughlin, C. T., Zhang, Z., Siryaporn, A., Silpe, J. E., Bassler, B. L., & Semmelhack, M. F. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5015082 · Cited by 66
Musthafa, K. S., Balamurugan, K., Pandian, S. K., & Ravi, A. V. (2012) · Journal of Basic Microbiology · doi:10.1002/jobm.201100292 · Cited by 66
Stacy, D. M., Quement, S. T. L., Hansen, C. L., et al. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob27155a · Cited by 66
Nakayama, K., Kawato, H. C., Watanabe, J., Ohtsuka, M., Yoshida, K., Yokomizo, Y., Sakamoto, A., Kuru, N., Ohta, T., Hoshino, K., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.060 · Cited by 66
Kim, O. K., Garrity-Ryan, L. K., Bartlett, V. J., Grier, M. C., Verma, A. K., Medjanis, G., Donatelli, J., Macone, A. B., Tanaka, S. K., Levy, S. B., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9006577 · Cited by 66
Page, M. G. P., & Bush, K. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.008 · Cited by 63
Yoshida, K., Nakayama, K., Yokomizo, Y., Ohtsuka, M., Takemura, M., Hoshino, K., Kanda, H., Namba, K., Nitanai, H., Zhang, J. Z., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.037 · Cited by 62
Substituted 2-Imino-5-arylidenethiazolidin-4-one Inhibitors of Bacterial Type III Secretion
Kline, T. B., Felise, H. B., Barry, K. C., Jackson, S. R., Nguyen, H. V., & Miller, S. I. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8004515 · Cited by 62
Gallium induces the production of virulence factors inPseudomonas aeruginosa
García‐Contreras, R., Peréz-Eretza, B., Lira‐Silva, E., Jasso‐Chávez, R., Coria‐Jiménez, R., Rangel-Vega, A., Maeda, T., & Wood, T. K. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12105 · Cited by 61
Harmon, D. E., Davis, A. J., Castillo, C., & Mecsas, J. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00364-10 · Cited by 60
Novel Type III Effectors in Pseudomonas aeruginosa
Burstein, D. E., Satanower, S., Simovitch, M., Belnik, Y., Zehavi, M., Yerushalmi, G., Ben‐Aroya, S., Pupko, T., & Banin, E. (2015) · mBio · doi:10.1128/mbio.00161-15 · Cited by 60
Nakayama, K., Ishida, Y., Ohtsuka, M., Kawato, H. C., Yoshida, K., Yokomizo, Y., Ohta, T., Hoshino, K., Otani, T., Kurosaka, Y., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.027 · Cited by 59
The reaction of Pseudomonas aeruginosa cytochrome c oxidase with carbon monoxide
Parr, S. R., Wilson, M. T., & Greenwood, C. (1975) · Biochemical Journal · doi:10.1042/bj1510051 · Cited by 58
Gilboa‐Garber, N. (1972) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(72)90204-8 · Cited by 58
Lešnik, U., Lukežič, T., Podgoršek, A., Horvat, J., Polak, T., Šala, M., Jenko, B., Harmrolfs, K., Ocampo-Sosa, A. A., Martínez-Martínez, L., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411028 · Cited by 55
The big and small of drug discovery
Moore, A. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor748 · Cited by 54
Identification of Elongation Factor G as the Conserved Cellular Target of Argyrin B
Nyfeler, B., Hoepfner, D., Palestrant, D., Kirby, C. A., Whitehead, L., Yu, R. K., Deng, G., Caughlan, R. E., Woods, A. L., Jones, A. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042657 · Cited by 54
Adamson, D. H., Krikstopaityte, V., & Coote, P. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv111 · Cited by 54
Zhu, J., Cai, X., Harris, T., Gooyit, M., Wood, M. R., Lardy, M. A., & Janda, K. D. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.03.012 · Cited by 54
Vollbrecht, L., Steinmetz, H., Höfle, G., et al. (2002) · The Journal of Antibiotics · doi:10.7164/antibiotics.55.715 · Cited by 52
Nakayama, K., Kuru, N., Ohtsuka, M., Yokomizo, Y., Sakamoto, A., Kawato, H. C., Yoshida, K., Ohta, T., Hoshino, K., Akimoto, K., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.007 · Cited by 51
Lu, C., Kirsch, B., Maurer, C. K., de Jong, J. C., Braunshausen, A., Steinbach, A., & Hartmann, R. W. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.016 · Cited by 50
Self-citationMoser, C. E., van Gennip, M., Bjarnsholt, T., Jensen, P. Ø., Lee, B., Hougen, H. P., Calum, H., Ciofu, O., Givskov, M., Molin, S., et al. (2009) · Apmis · doi:10.1111/j.1600-0463.2008.00018.x · Cited by 49
Yoshida, K., Nakayama, K., Kuru, N., Kobayashi, S., Ohtsuka, M., Takemura, M., Hoshino, K., Kanda, H., Zhang, J. Z., LEE, V. J., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.10.043 · Cited by 49
Lanne, B., C�opraga, J., Bergstr�m, J., et al. (1994) · Glycoconjugate Journal · doi:10.1007/bf00731201 · Cited by 49
Vidal-Aroca, F., Meng, A., Minz, T., Page, M. G. P., & Dreier, J. (2009) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2009.09.021 · Cited by 47
Wurst, J., Drake, E. J., Thériault, J. R., Jewett, I. T., VerPlank, L., Perez, J. R., Dandapani, S., Palmer, M. A. J., Moskowitz, S. M., Schreiber, S. L., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb5001586 · Cited by 46
Jolly, A. L., Takawira, D., Oke, O. O., Whiteside, S. A., Chang, S. W., Wen, E. R., Quach, K., Evans, D. J., & Fleiszig, S. M. J. (2015) · mBio · doi:10.1128/mbio.02533-14 · Cited by 46
Sahner, J. H., Brengel, C., Storz, M. P., Groh, M., Plaza, A., Müller, R., & Hartmann, R. W. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401102e · Cited by 45
Self-citationStorz, M. P., Allegretta, G., Kirsch, B., Empting, M., & Hartmann, R. W. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00707g · Cited by 44
Self-citationSommer, R., Hauck, D., Varrot, A., Wagner, S., Audfray, A., Prestel, A., Möller, H. M., Imberty, A., & Titz, A. (2015) · ChemistryOpen · doi:10.1002/open.201500162 · Cited by 42
Self-citationPalliyil, S., Downham, C., Broadbent, I. D., Charlton, K. A., & Porter, A. J. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02912-13 · Cited by 41
Williams, J. D., Torhan, M. C., Neelagiri, V. R., Brown, C. L., Bowlin, N. O., Di, M., McCarthy, C. T., Aiello, D. A., Peet, N. P., Bowlin, T. L., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.011 · Cited by 40
Sommer, R., Exner, T. E., & Titz, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112822 · Cited by 40
Self-citationCatechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD
Allegretta, G., Weidel, E., Empting, M., & Hartmann, R. W. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.055 · Cited by 40
Self-citationGarner, A. L., Struss, A. K., Fullagar, J. L., Agrawal, A., Moreno, A. Y., Cohen, S. M., & Janda, K. D. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300128f · Cited by 39
Hinsberger, S., de Jong, J. C., Groh, M., Haupenthal, J., & Hartmann, R. W. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.014 · Cited by 37
Self-citationBielecki, P., Lukat, P., Hüsecken, K., Dötsch, A., Steinmetz, H., Hartmann, R. W., Müller, R., & Häußler, S. (2012) · ChemBioChem · doi:10.1002/cbic.201200479 · Cited by 36
Self-citationClevenger, K. D., Wu, R., Er, J. A. V., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400345h · Cited by 36
Yang, S., Abdel-Razek, O. A., Cheng, F., Bandyopadhyay, D., Shetye, G. S., Wang, G., & Luk, Y. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.01.004 · Cited by 34
Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC
Warmus, J. S., Quinn, C. L., Taylor, C. B., Murphy, S. T., Johnson, T. A., Limberakis, C., Ortwine, D. F., Bronstein, J. C., Pagano, P. J., Knafels, J. D., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.140 · Cited by 34
Kida, Y., Taira, J., Yamamoto, T., Higashimoto, Y., & Kuwano, K. (2013) · Cellular Microbiology · doi:10.1111/cmi.12106 · Cited by 33
Stauch, B., Simon, B., Basile, T., Schneider, G., Malek, N. P., Kalesse, M., & Carlomagno, T. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000140 · Cited by 32
Schweizer, F., Jiao, H., Hindsgaul, O., Wong, W. Y., & Irvin, R. T. (1998) · PubMed · Cited by 31
Murphy-Benenato, K. E., Bhagunde, P. R., Chen, A., Davis, H. E., Durand-Réville, T. F., Ehmann, D. E., Galullo, V., Harris, J. J., Hatoum‐Mokdad, H., Jahić, H., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501506f · Cited by 30
Storz, M. P., Brengel, C., Weidel, E., Hoffmann, M., Hollemeyer, K., Steinbach, A., Müller, R., Empting, M., & Hartmann, R. W. (2013) · ACS Chemical Biology · doi:10.1021/cb400530d · Cited by 29
Self-citationValidation of 3D EM Reconstructions: The Phantom in the Noise
Heymann, J. B. (2015) · AIMS Biophysics · doi:10.3934/biophy.2015.1.21 · Cited by 26
Lipopolysaccharide rolls out the barrel
Bishop, R. E. (2014) · Nature · doi:10.1038/nature13508 · Cited by 24
Faure, L. M., Garvis, S., de Bentzmann, S., & Bigot, S. (2014) · Microbiology · doi:10.1099/mic.0.079616-0 · Cited by 23
Moir, D. T., Di, M., Wong, E., Moore, R. A., Schweizer, H. P., Woods, D. E., & Bowlin, T. L. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111408605 · Cited by 23
Effect of cyclic bis(3′–5′)diguanylic acid and its analogs on bacterial biofilm formation
Ishihara, Y., Hyodo, M., Hayakawa, Y., et al. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01825.x · Cited by 22
Halebeedu, P. P., Kumar, G. V., & Gopal, S. (2014) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.129766 · Cited by 14
Cited by
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Self-citationDifferent drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
Annunziato, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235844 · Cited by 256
Metadata
- Authors
- Wagner, S., Sommer, R., Hinsberger, S., Lu, C., Hartmann, R. W., Empting, M., & Titz, A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-02-18
- Volume
- 59
- Issue
- 13
- Pages
- 5929-5969
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2291776655
- Cited by
- 258
- References
- 337
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.